Ian Read

Showing 15 posts of 16 posts found.

ianread

Pfizer CEO Ian Read’s pay packet cut from $27.9m to $19.5m

March 15, 2019
Medical Communications CEO, Ian Read, Pfizer, compensation, pay packet, salary

Ian Read has seen his total compensation cut from a sum of $27.9 million in 2018 to $19.5 million this …

Pfizer announce cull of 2% of staff

October 18, 2018
Business Services, Medical Communications, Sales and Marketing Bourla, Ian Read, Jobs, Pfizer, america, layoffs

US pharma giant Pfizer is offering early retirement to American workers ahead of layoffs scheduled for next year. The company …

ianread

Ian Read steps down as Pfizer CEO

October 4, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Ian Read, Pfizer, pharma

Ian Read is set to step down from his position as Chief Executive Officer (CEO) of American pharma firm Pfizer, …

ianread

Pfizer CEO Ian Read set to step down from head position

October 1, 2018
Manufacturing and Production, Sales and Marketing Albert Bourla, CEO, COO, Ian Read, Pfizer, Stock Markets

Ian Read is set to step down from his position as Chief Executive Officer (CEO) of American pharma firm Pfizer, …

ianread

Pharma CEO Ian Read forcasts rebate-free drug market

August 1, 2018
Research and Development CEO, Ian Read, PBMs, Pfizer, Rebates

The CEO of American multinational Pfizer has said that he believes the Trump administration will eliminate rebates on prescription drug …

shutterstock_254160583

Trump forces Pfizer to back down and delay price hikes until 2019

July 11, 2018
Research and Development, Sales and Marketing Alex Azar, Donald Trump, Ian Read, Pfizer, President trump, Trump, druig pricing, pharma

Trump bared his teeth, and it paid off. Following his call-out of Pfizer after the US pharma giant ignored the …

Pfizer to hang onto CEO, after 61% pay increase

March 19, 2018
Medical Communications, Sales and Marketing Ian Read, Pfizer, biotech, drugs, pharma, pharmaceutical

Pfizer have given its Chief Executive Officer, Ian Read, a big boost to his pay packet, taking it to $27.9 …

Pfizer decides not to break up business

September 26, 2016
Sales and Marketing Ian Read, Pfizer, United States, america

In the intervening four years, Pfizer has conducted “extensive evaluation” into the possibility, with the company reorganising into two distinct …

Pfizer revenues down, but above expectations

February 3, 2016
Research and Development, Sales and Marketing Ian Read, Pfizer, financial results, income, profits, revenue, sales

Pfizer’s revenues took a hit from generic competition on former blockbusters, but the world’s new largest drugmaker still managed to …

Ken Frazier image

Merck chief executive replaces Pfizer boss as PhRMA chairman

April 17, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing George Scangos, Ian Read, Joaquin Duato, Kenneth Frazier, PhRMA

Chairman and chief executive of Merck Kenneth Frazier is to replace Pfizer boss Ian Read as chairman at the Pharmaceutical …

Pfizer sales shrink 9 per cent

April 30, 2013
Sales and Marketing Ian Read, Lipitor, Pfizer

Pfizer endured another painful cut to its revenues in the first quarter of 2013, with sales down $1.4 billion, or …

Pfizer stumbles in third quarter

November 2, 2012
Research and Development, Sales and Marketing Ian Read, Lipitor, Pfizer, Prevnar, Q3

Pfizer has experienced a worse than expected third quarter, due to disappointing sales of paediatric vaccine Prevnar and a surprise …

Pfizer image

Pfizer to create standalone animal health business

June 8, 2012
Sales and Marketing Ian Read, Pfizer, Zoetis, nestle, standalone

Pfizer has said it is setting up a new standalone company out of its animal health division. This means it …

ianreadweb

Ian Read elected as chairman of the board at Pfizer

December 13, 2011
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Ian Read, Kindler, Pfizer

Pfizer’s chief executive and president Ian Read has been elected as the firm’s new chairman. Read succeeds George Lorch as …

Dr Steve Yang

Double blow to Pfizer’s emerging markets strategy

December 10, 2010
Business Services, Sales and Marketing David Simmons, Ian Read, Jean-Michel Halfon, Jeffrey Kindler, Pfizer, Steve Yang, emerging pharma markets, recruitment

Pfizer has lost two senior executives with key roles in its emerging markets strategy. The departure of the company’s head …

Latest content